Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma
Titel:
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma
Auteur:
Alexander, A.N. Huelsmeyer, M.K. Mitzey, Ann Dubielzig, R.R. Kurzman, I.D. MacEwen, E.G. Vail, D.M.